Your browser is no longer supported. Please, upgrade your browser.
Settings
PRPO Precipio, Inc. daily Stock Chart
PRPO [NASD]
Precipio, Inc.
Index- P/E- EPS (ttm)-19.33 Insider Own20.77% Shs Outstand12.14M Perf Week19.21%
Market Cap5.50M Forward P/E- EPS next Y- Insider Trans- Shs Float10.14M Perf Month5.30%
Income-32.20M PEG- EPS next Q- Inst Own11.40% Short Float5.85% Perf Quarter-36.08%
Sales1.70M P/S3.23 EPS this Y26.50% Inst Trans131.06% Short Ratio0.36 Perf Half Y-64.05%
Book/sh1.30 P/B0.35 EPS next Y- ROA-131.90% Target Price7.00 Perf Year-95.42%
Cash/sh0.03 P/C13.75 EPS next 5Y20.00% ROE-407.40% 52W Range0.36 - 28.16 Perf YTD-62.25%
Dividend- P/FCF- EPS past 5Y31.70% ROI-105.20% 52W High-98.39% Beta0.59
Dividend %- Quick Ratio0.20 Sales past 5Y-44.10% Gross Margin16.90% 52W Low25.83% ATR0.05
Employees19 Current Ratio0.20 Sales Q/Q200.00% Oper. Margin- RSI (14)51.40 Volatility17.83% 10.21%
OptionableNo Debt/Eq0.27 EPS Q/Q44.30% Profit Margin- Rel Volume0.74 Prev Close0.43
ShortableYes LT Debt/Eq0.22 Earnings- Payout- Avg Volume1.66M Price0.45
Recom- SMA209.42% SMA50-4.77% SMA200-68.82% Volume1,230,504 Change5.64%
May-17-18 07:38AM  Precipio Launches ICE COLD-PCR Liquid Biopsy Kit for Pancreatic Cancer GlobeNewswire +6.96%
May-15-18 08:00AM  Todays Research Reports on Stocks to Watch: Precipio and Teva Pharmaceutical ACCESSWIRE -11.20%
May-14-18 07:37AM  Precipio Announces Preliminary Q1 2018 Year-over-Year Revenue Increase of 286% GlobeNewswire +25.18%
Apr-26-18 07:38AM  Precipio Announces Participation Details for Upcoming Shareholder Conference Call GlobeNewswire
Apr-23-18 07:37AM  Precipio Completes a $3M Convertible Debt Facility GlobeNewswire
Apr-18-18 07:38AM  Precipio in Strategic Partnership Discussions for Proprietary Cytogenetics Media IV-Cell GlobeNewswire +5.72%
Apr-17-18 07:37AM  Precipio Releases its 2017 10-K, Files a form S-1, and hosts Fourth Quarter and Full Year Update Call GlobeNewswire
Apr-11-18 07:37AM  Precipio Launches ICE COLD-PCR Research Access Program for Cancer Centers GlobeNewswire +10.20%
Apr-10-18 12:23PM  Precipio Inc (NASDAQ:PRPO): Time For A Financial Health Check Simply Wall St.
Apr-03-18 07:38AM  Important JAMA Article Underscores Superiority of Precipios Liquid Biopsy Core Technology GlobeNewswire -8.92%
Mar-28-18 07:37AM  Precipio Files Patent for Non-Invasive Cell Capture Device For Gynecological Cancer Detection GlobeNewswire +5.78%
Mar-26-18 07:38AM  Precipio Enters India Liquid Biopsy Market with Adoption by Leading Laboratory GlobeNewswire
Mar-22-18 07:37AM  Precipio Restructures Capitalization Table GlobeNewswire -9.84%
Mar-20-18 07:37AM  Precipio Integrates Cost Reducing and Fast Turnaround "High Resolution Melt" into Liquid Biopsy Platform GlobeNewswire +88.82%
Mar-13-18 08:38AM  Precipio Settles Lawsuit with Crede Capital GlobeNewswire +21.02%
Feb-22-18 08:39AM  Key Measure of Precipios Pathology Sales Growth 4X Prior Quarter GlobeNewswire +7.50%
Feb-15-18 08:38AM  Precipio Launches Unique Lung Cancer Monitoring Test for Therapy Resistance GlobeNewswire -6.49%
Feb-09-18 09:00AM  Precipio Announces Q4 2017 Revenue at 350% of Previous Quarter GlobeNewswire -14.43%
Feb-06-18 08:37AM  Precipio Enters Japanese Liquid Biopsy Market with First Hospital Sale GlobeNewswire
Jan-22-18 08:27AM  Precipio Commences Validation Study of Proprietary IV-Cell Cytogenetics Media at University of Pennsylvania GlobeNewswire
Jan-16-18 08:27AM  Precipio Appoints New Sales VP to Manage Diagnostics Sales Expansion GlobeNewswire -8.46%
Jan-10-18 08:27AM  Yale Study Demonstrates Four-Fold Superiority of Academic Level Diagnostic Accuracy GlobeNewswire
Dec-20-17 08:00AM  Precipio Launches Its Second New ICE-COLD PCR Targeted Enrichment Kit To Identify Mutations in Lung Cancer Using Liquid (Blood) Biopsies On Sanger Sequencing Platforms GlobeNewswire +6.49%
Dec-15-17 09:00AM  OrthoPediatrics Corp. Appoints Samuel D. Riccitelli to its Board of Directors GlobeNewswire -9.17%
Dec-14-17 08:00AM  Precipio Files a Patent Application for IV-Cell, its Novel Cytogenetics Media GlobeNewswire +9.09%
Dec-01-17 07:57AM  Precipio, Inc. :PRPO-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017 Capital Cube
Nov-21-17 07:00AM  Precipio, Inc. to Host Earnings Call ACCESSWIRE
Nov-20-17 04:05PM  Precipio Announces Third Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire -5.15%
Nov-16-17 04:15PM  Precipio To Announce Third Quarter 2017 Financial Results and Provide a Company Update on Monday, November 20, 2017 at 4:05pm Eastern Time GlobeNewswire +7.94%
Nov-14-17 04:15PM  Precipio Appoints Samuel D. Riccitelli as Chairman of the Board of Directors and Elects David Cohen as Director GlobeNewswire
Precipio, Inc. provides platform to eradicate the problem of misdiagnosis within academic institutions. The company also delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.